
FDA Drug information
Erzofri extended-release
- Erzofri extended-release PALIPERIDONE PALMITATE 117 mg/.75mL Shandong Luye Pharmaceutical Co., Ltd.
- Erzofri extended-release PALIPERIDONE PALMITATE 156 mg/mL Shandong Luye Pharmaceutical Co., Ltd.
- Erzofri extended-release PALIPERIDONE PALMITATE 234 mg/1.5mL Shandong Luye Pharmaceutical Co., Ltd.
- Erzofri extended-release PALIPERIDONE PALMITATE 351 mg/2.25mL Shandong Luye Pharmaceutical Co., Ltd.
- Erzofri extended-release PALIPERIDONE PALMITATE 39 mg/.25mL Shandong Luye Pharmaceutical Co., Ltd.
- Erzofri extended-release PALIPERIDONE PALMITATE 78 mg/.5mL Shandong Luye Pharmaceutical Co., Ltd.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.